Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark S. Watkins
Mark S. Watkins
GlaxoSmithKline
Cancer research
Internal medicine
Biology
Endocrinology
Daprodustat
2
Papers
12
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates.
2020
PLOS ONE
Susan B. Laffan
Andrew S. Thomson
Shing Mai
Cindy Fishman
Takahito Kambara
Kiran Nistala
James T. Raymond
Shugui Chen
Thulasi Ramani
Laura Pageon
Rodd Polsky
Mark S. Watkins
Gemma Ottolangui
John R. White
Curtis Maier
Michael Herdman
Gerben Bouma
Show All
Source
Cite
Save
Citations (5)
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor:
2019
Toxicologic Pathology
David F. Adams
Mark S. Watkins
Luc Durette
Josée Laliberté
Félix Goulet
Elaine Debien
Kendall S. Frazier
Nacera Mellal
Liangfu Chen
Wei Shi
Roberta A. Thomas
Erding Hu
Show All
Source
Cite
Save
Citations (7)
1